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Abstract
During prolonged fasting, fatty acid (FA) released from adipose tissue is a major energy source for peripheral tissues,
including the heart, skeletal muscle and liver. We recently showed that FA binding protein 4 (FABP4) and FABP5, which are
abundantly expressed in adipocytes and macrophages, are prominently expressed in capillary endothelial cells in the heart
and skeletal muscle. In addition, mice deficient for both FABP4 and FABP5 (FABP4/5 DKO mice) exhibited defective uptake
of FA with compensatory up-regulation of glucose consumption in these tissues during fasting. Here we showed that
deletion of FABP4/5 resulted in a marked perturbation of metabolism in response to prolonged fasting, including
hyperketotic hypoglycemia and hepatic steatosis. Blood glucose levels were reduced, whereas the levels of non-esterified
FA (NEFA) and ketone bodies were markedly increased during fasting. In addition, the uptake of the
125I-BMIPP FA analogue
in the DKO livers was markedly increased after fasting. Consistent with an increased influx of NEFA into the liver, DKO mice
showed marked hepatic steatosis after a 48-hr fast. Although gluconeogenesis was observed shortly after fasting, the
substrates for gluconeogenesis were reduced during prolonged fasting, resulting in insufficient gluconeogenesis and
enhanced hypoglycemia. These metabolic responses to prolonged fasting in DKO mice were readily reversed by re-feeding.
Taken together, these data strongly suggested that a maladaptive response to fasting in DKO mice occurred as a result of an
increased influx of NEFA into the liver and pronounced hypoglycemia. Together with our previous study, the metabolic
consequence found in the present study is likely to be attributed to an impairment of FA uptake in the heart and skeletal
muscle. Thus, our data provided evidence that peripheral uptake of FA via capillary endothelial FABP4/5 is crucial for
systemic metabolism and may establish FABP4/5 as potentially novel targets for the modulation of energy homeostasis.
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Introduction
Mammals have evolved a metabolic response system that
enables them to survive for longer periods of food deprivation. The
overall metabolic response to fasting operates at numerous levels
and has been relatively well characterized [1–5]. In the fasted
state, most tissues, except the brain and red blood cells, rely
heavily on the direct utilization of fatty acids (FA) to generate
energy. Prolonged fasting promotes the hydrolysis of triacylgly-
cerol (TG) in adipose tissue, thereby increasing the concentration
PLOS ONE | www.plosone.org 1 November 2013 | Volume 8 | Issue 11 | e79386of non-esterified FA (NEFA) in plasma. Circulating FAs are taken
up by the liver, where NEFA is either re-esterified to TG and
secreted as very low density lipoprotein (VLDL), oxidized to
synthesize adenosine triphosphate (ATP) in the mitochondria via
b-oxidation or converted into ketone bodies that are used by many
tissues, including the brain, during starvation.
Cytoplasmic fatty-acid-binding proteins (FABPs) actively facil-
itate the transport of lipids to specific compartments in cells.
FABP4 (also known as aP2/ALBP/A-FABP) and FABP5 (also
referred to as mal1/E-FABP) play important roles in the
pathogenesis of metabolic diseases. Although mice deficient for
either FABP4 or FABP5 demonstrate a modest phenotype due to
their redundant function [6,7], mice lacking both Fabp4 and Fabp5
(DKO mice) displayed a dramatic phenotype in their metabolism,
including robust protection against diet-induced obesity, insulin
resistance, type 2 diabetes, atherosclerosis, and fatty liver disease
[8,9]. This phenotype has been attributed to several potential
mechanisms. First, the predominant feature of the metabolic
phenotype is related to adipocyte FABPs with a more modest
contribution from macrophages [10]. In addition, the increased
supply of adipose tissue palmitoleate (C16:1n7, also termed
lipokine) or the increase in the ratio of shorter chain FAs (C14)
to the longer chain (C18) in adipose and muscle tissues may also be
candidates to mediate the improvement of insulin sensitivity and
protection from fatty livers [9,11]. Immunohistochemical analyses
by several groups revealed that both FABP4/5 are also expressed
in capillary endothelial cells in various organs, including the heart,
skeletal muscle and adipose tissue [12,13], suggesting a role of
FABP4/5 in FA transport across capillary endothelial cells in these
tissues. Very recently, we showed that DKO mice exhibited
defective trans-endothelial FA transport with remarkable glucose
uptake in the heart and red skeletal muscle in DKO mice during
fasting, which was independent of insulin [14].
In this study, we showed that deletion of FABP4/5 resulted in a
marked perturbation of metabolism in response to prolonged
fasting, including hyperketotic hypoglycemia and prominent
hepatic steatosis. Importantly, our data suggested that hepatic
steatosis occurred not as a result of reduced FA oxidation (FAO),
but rather from an increased influx of NEFA, which was likely
attributed to an impairment in FA uptake in the heart and skeletal
muscle in DKO mice.
Results
Blood Glucose is Decreased while NEFA and Ketone
Bodies are Increased during Prolonged Fasting
We first studied several biochemical parameters of serum levels
(figure 1). Glucose levels were significantly lower in DKO mice
compared to wild-type (WT) mice after a 24- and 48-hr fast
without a significant difference in the insulin level. The serum level
of NEFA was also reciprocally increased in DKO mice, which was
consistent with a lower uptake of FA by peripheral tissues during
fasting [14]. In parallel with NEFA, the serum level of ketone body
(b-hydroxybutyrate, BHB), a final product of ketogenesis, was
enhanced in DKO mice as the fasting progressed. The serum
glucagon level was also higher in DKO mice, which may function
against lower glucose levels and promote lipolysis. TG and total
cholesterol were comparable before and after fasting.
Despite extreme hypoglycemia in DKO mice, their physical
activity was not reduced. Indeed, the locomotor activity was
comparable between WT and DKO mice during prolonged
fasting, although it tended to be reduced in the fed state (figure 2).
We assumed that this conserved physical activity was attributed to
a higher level of ketone bodies that could be utilized in many
organs, including the brain, heart and skeletal muscle.
Prolonged Fasting Causes Prominent Fatty Livers
While hepatic TG accumulation did not appear to significantly
differ between WT and DKO mice after a 24-hr fast, DKO mice
exhibited prominent TG accumulation in the liver after a 48-hr
fast (figure 3A, 3B and 3C). Although body weight was decreased
in a time-dependent manner, liver weight was maintained in DKO
mice, resulting in a higher ratio of liver weight to body weight
(Figure 3D). In addition, there was a slightly smaller reduction in
body weight in DKO mice after a 48-hr fast (figure 3D).
Importantly, FABP4/5 expression was very low in the WT liver
and was hardly detected in the sinusoidal endothelium using
immunohistochemisty [14]. The expression of other genes
associated with FA uptake in the liver, such as FABP1 and FAT
(fatty acid translocase)/CD36, did not change in DKO mice
compared to WT, although the expression level of FATP2 (fatty
acid transport protein 2) was reduced after a 24- and 48-hr fast
(figure 3E). These findings suggested that inducible expression of
the genes relevant to FA uptake did not contribute to a large
increase in FA uptake by the liver in DKO mice.
We next examined FA uptake in the liver during prolonged
fasting using the FA analogue
125I-BMIPP. As expected, the
uptake of
125I-BMIPP was markedly up-regulated after a 24- and
Figure 1. Blood glucose is decreased while serum levels of FFA
and ketone bodies are markedly increased during prolonged
fasting in DKO mice. Blood was collected from the vena cava inferior
before (0-hr) and after fasting (24- and 48-hr) to measure blood glucose,
NEFA, insulin, ketone bodies (BHB), triacylglycerol (TG) and cholesterol.
n=7211/group. Blood was sampled from the retro-orbital plexus for
plasma glucagon. n=6/group. Data are shown as the mean 6 SE. WT
vs. DKO. !p,0.05, !!p,0.01, !!!p,0.001.
doi:10.1371/journal.pone.0079386.g001
FABP4/5-Null Mice with Defective Peripheral FA Use
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18F-FDG uptake (figure 3F
and 3G). Hepatocytes isolated from WT and DKO mice
demonstrated a comparable ability to take up
14C-palmitic acid
in a dose-dependent manner (figure 3H).
Taken together, these findings suggested that prolonged fasting
triggered abundant lipid accumulation in the liver, which was not
due to compensatory gene regulation by FABP4/5 deletion, but
rather due to an increase in serum NEFA released from peripheral
adipose tissue.
Reduced VLDL Secretion Enhances TG Deposits in the
Liver in DKOs
Very low density lipoprotein (VLDL) is assembled in hepato-
cytes and is directly secreted into the circulation to supply energy
to extra hepatic tissues [15]. Thus, we determined the VLDL
production rate by measuring temporal increases in plasma TG
under conditions where TG hydrolysis by lipoprotein lipase (LPL)
was inhibited. Interestingly, TG export was reduced in DKO mice
during fasting (Figure 4A and 4B) despite the enhanced uptake of
NEFA (Figure 3F). This result was concomitant with a lower
expression of genes associated with VLDL formation, such as Apo-
B100, in the liver of DKO mice (Figure 4C). Thus, the reduced
secretion of VLDL from the liver could enhance pronounced fatty
liver.
FA synthesis was generally suppressed during fasting. Consistent
with this finding, the expression of mRNA for ELOVL6 and
SCD1, which are enzymes involved in FA synthesis, were
markedly reduced after a 24- and 48-hr fast in both WT and
DKO mice (figure 4D). The expression of mRNA for FAS and
ACC was not significantly different between WT and DKO mice.
In DKO mice, the expression of SCD1 was significantly lower
compared to WT mice after a 24-hr fast, suggesting that lipid
accumulation in the DKO liver was not due to enhanced FA
synthesis.
Materials Associated with FAO are Decreased in the
Livers of DKO Mice
Hepatic fat accumulation was also accelerated when FAO
was disrupted [1–5]. Thus, we next examined the expression
levels of the genes regulating FAO. The expression levels of
carnitinepalmitoyltransferase 1a (CPT1a), a key enzyme for
acyl-CoA transport into mitochondria, were lower in DKO
livers despite the high expression of peroxisome proliferator-
activated receptor a (PPARa) after a 48-hr fast (Figure 5A). The
expression levels of CPT2 and acyl-CoA synthetase long-chain
family member 1 (ACSL1), an enzyme that converts FA into
acyl-CoA, were comparable between WT and DKO livers.
Metabolome analysis revealed that L-carnitine, a carrier for acyl
groups in the mitochondrial membrane, and Coenzyme A
(CoA), an essential coenzyme for shuttling acyl groups and b-
oxidation, were lower in DKO livers (figure 5B), suggesting that
FA transport into the mitochondria and subsequent b-oxidation
declined during fasting. Consistent with the decreased levels of
L-carnitine and CoA, substrates for both L-carnitine (lysine and
methionine) and CoA (cysteine) were significantly reduced
(Table 1). NAD (nicotinamide adenosine dinucleotide), an
indispensable coenzyme for b-oxidation, was also markedly
reduced (figure 5B). Furthermore, its energy-rich reduced form
NADH was also decreased (figure 5B). Consistent with this
finding, tryptophan, a substrate for NAD, decreased during
fasting (table 1). Flavin adenine dinucleotide (FAD), another
coenzyme required for b-oxidation, was also reduced (figure 5B).
Taken together, these findings suggested that NEFA taken up in
the liver could be converted into acyl-CoA, although the
reduced amount of other substrates, such as CPT1a, L-
carnitine, CoA, NAD, and FAD, might limit the subsequent
catabolism of FAs during prolonged fasting.
Capacity to Oxidize FA is Enhanced in DKO Livers
We next estimated the capacity of hepatocytes to oxidize FA
using primary cultures and liver extracts. Both hepatocytes from
WT and DKO mice showed a comparable FAO capacity,
suggesting that the basal capacity of FAO in DKO hepatocytes
was conserved (figure 5C). Unexpectedly, the estimated FAO rate
in vitro using liver extracts prior to fasting was higher in the DKO
compared to WT mice (figure 5D). A higher FAO in DKO
extracts was also observed after a 48-hr fast despite a marked
reduction in crucial cofactors, such as L-carnitine, CoA, NAD,
and FAD, although it tended to decrease in a time-dependent
manner after fasting (figure 5D). Because FA oxidation in the liver
is regulated by multiple factors, such as fasting and the levels of
glucose and glucagon [16,17], the difference in
14C-palmitic acid
oxidation between isolated hepatocytes and liver homogenates
might be due to such circulating factors.
Figure 2. Locomotor activity is comparable between WT and
DKO mice. Locomotor activity was measured during feeding and
fasting (0–24 and 24–48 hr). Data are presented for 12 hours of the light
phase, 12 hours the dark phase and combined light and dark phase
(24 hr).
doi:10.1371/journal.pone.0079386.g002
FABP4/5-Null Mice with Defective Peripheral FA Use
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Re-feeding in DKO Mice
To determine the reversibility of fasting-induced hepatic
steatosis in DKO mice, mice were re-fed after 48-hour of
fasting (Figure 6). The liver color returned to a reddish color
after one day of re-feeding. The TG content in the liver also
decreased to nearly 50% on the first day after re-feeding. In
addition, the serum levels of BHB and NEFA were dramatically
Figure 3.TG accumulation is enhanced in DKO livers during prolonged fasting. (A to E) Livers were isolated before (0 hour) and after
fasting (24- and 48-hr). (A) Representative gross appearance of the liver. (B) Oil red O staining. Scale bar=100 mm. (C) Triglyceride content in the liver
(mg/mg protein). (D) Body weight (BW), % reduction in BW after fasting, liver weight (LW), ratio of LW relative to BW (LW/BW, mg/g). n=11/group. (E)
The expression of genes involved in FA uptake was determined using quantitative real-time PCR. (F and G) Mice received intravenous injections of
125I-BMIPP (5 kBq) and
18F-FDG (100 kBq) via the lateral tail vein before (0-hr) and after fasting (24- and 48-hr). The animals were sacrificed at 2 hours
after injection. Uptake of
125I-BMIPP (F) and
18F-FDG (G) by the liver was quantified using a well-type gamma counter (n=4). (H) Hepatocytes were
isolated from WT and DKO livers. Uptake of
14C-palmitic acid (
14C-PA) by hepatocytes was measured using a liquid scintillation counter. Note that
uptake of
14C-PA was comparable between WT and FABP4/5 DKO hepatocytes. In addition, the uptake was proportional to the loading dose of
14C-PA. n=6/group. Data are shown as the mean 6 SE. WT vs. DKO. !p,0.05, !!p,0.01, !!!p,0.001, ns= not significant.
doi:10.1371/journal.pone.0079386.g003
FABP4/5-Null Mice with Defective Peripheral FA Use
PLOS ONE | www.plosone.org 4 November 2013 | Volume 8 | Issue 11 | e79386decreased after re-feeding while the blood glucose returned to
levels that were equivalent to normally fed mice. These findings
were consistent with our assumption that prominent fatty livers
in DKO mice after prolonged fasting was enhanced by an
increased level of serum NEFA. Moreover, TG deposits in the
liver were reduced when the NEFA level was markedly
decreased by re-feeding.
Impaired Glucose Homeostasis in DKO Mice
We next addressed the effects of FABP4/5 deletion on
carbohydrate metabolism. Glycogen content in the liver was more
remarkably reduced in DKO mice during prolonged fasting
(figure 7A), suggesting an accelerated breakdown of glycogen
against lower blood glucose levels. Lower glycogen storage during
fasting was also confirmed using PAS staining (Figure 7B). An
increased level of serum glucagon (figure 1) further supported this
hypothesis of accelerated glycogen utilization.
During fasting, glucose is generated from non-carbohydrate
precursors, such as lactate and amino acids, mainly in the liver
during gluconeogenesis[18–21]. Although lactate and amino
acids (specifically alanine) maybe supplied from red blood cells
and muscle, such substrates present in the liver are also utilized
for gluconeogenesis. Metabolome analysis revealed that most
precursors in gluconeogenesis (lactate and glucogenic amino
acids, such as alanine, asparagine and serine) were significantly
reduced after a 48-hr fast (figure 7C and table 1), which
strongly suggested that more abundant energy substrates were
consumed in the livers of DKO mice via accelerated
gluconeogenesis. One exception was glutamate, a central hepatic
amino acid, which demonstrated higher levels in the DKO liver.
Because glutamate plays a role in the transamination/deamina-
tion process and enters into the TCA cycle as a-ketoglutarate
[19], it can be increased as an intermediate in these pathways.
An increase in glutamate concentration during fasting suggests
that facilitation of the glutamate synthesis process, or breakdown
of other amino acids for gluconeogenesis, was enhanced at least
transiently. An increase in the glucagon/insulin ratio in DKO
mice (figure 1) further suggested that DKO mice required more
gluconeogenesis. Moreover, metabolome analysis showed that
key molecules for gluconeogenesis, such as NAD, NADH and
guanosine triphosphate (GTP), were more markedly reduced in
the DKO liver (figure 5B and 7D). GTP is usually converted
from ATP by a nucleoside disphosphate kinase reaction. ADP, a
precursor for ATP, was also reduced in the DKO liver. A
reduction in GTP as well as ADP may reflect the diminished
ATP synthesis rate during prolonged fasting.
The expression of a key enzyme for gluconeogenesis, phos-
phoenolpyruvatecarboxykinase (PEPCK1), was comparable prior
to fasting, although it was significantly lower in the DKO liver
after a 24- and 48-hr fast (figure 7E). These findings suggested that
the basal ability of gluconeogenesis was comparable in DKO mice
during a short period of fasting, but continued to decline during
fasting.
To directly examine the extent of gluconeogenesis, a pyruvate
challenge test was performed to measure the blood glucose in
response to intra-peritoneal administration of pyruvate (a major
gluconeogenic substrate). As expected, DKO mice were com-
promised in the pyruvate challenge after 24-hr fast (figure 7F).
However, the level of gluconeogenesis was comparable after a 3-
hr fast (figure 7F), suggesting that materials for gluconeogenesis
were available shortly after fasting. Taken together, reduced
gluconeogenesis in the DKO liver during prolonged fasting was
likely due to a marked reduction in gluconeogenic materials such
as lactate, amino acids, GTP, NAD and NADH via accelerated
consumption.
Figure 4. VLDL secretion is reduced in DKO mice after fasting. (A) Serum levels of TG were measured at the indicated time points after an
intravenous injection of triton WR 1339 (500 mg/kg). (B) The VLDL production rate (mg/kg/hour) was calculated from the TG concentration of (A).
n=528/group. (C) The expression of ApoB100 was determined using quantitative real-time PCR. n=4/group. Data are shown as the mean 6 SE.WT
vs. DKO. !p,0.05. (D) The expression of genes involved in FA synthesis was determined using quantitative real-time PCR.
doi:10.1371/journal.pone.0079386.g004
FABP4/5-Null Mice with Defective Peripheral FA Use
PLOS ONE | www.plosone.org 5 November 2013 | Volume 8 | Issue 11 | e79386Ketogenesis is Accelerated by the Enhanced Expression
of Ketogenesis-associated Genes
We found the serum level of BHB was higher in DKO mice
during fasting (figure 1). Consistent with this finding, the level of
BHB was higher in the DKO liver while the level of acetyl-CoA, a
material for ketogenesis, was comparable (figure 8A). RT-PCR
further revealed that the expression of genes for ketogenesis, such
as 3-hydroxy-3-methylglutaryl-CoA synthase 2 (HMGCS2) and 3-
hydroxymethyl-3-methylglutaryl-CoA lyase (HMGCL), were re-
markably higher in DKO livers after a 48-hr fast (Figure 8B). In
addition, the expression of fibroblast growth factor 21 (FGF21),
which is associated with ketogenesis as a direct target gene of
PPARa in response to fasting [22,23], was markedly higher in
DKO livers after a 48-hr fast (Figure 8B). These findings suggested
that the enhanced expression of these ketogenic genes during
fasting may at least partially accelerate ketogenesis in DKO mice.
Discussion
Our study established that FABP4/5 play a critical role in the
systemic response to prolonged fasting. The major findings of this
study included the following: first, the blood glucose concentration
was significantly lower while serum levels of NEFA and ketone
bodies were significantly higher during prolonged fasting in DKO
mice (hyperketotic hypoglycemia). Second, prolonged fasting
markedly induced hepatic steatosis in DKO mice. Third, FAO
was enhanced during the fed state, and higher levels of FAO were
maintained even after prolonged fasting. Fourth, gluconeogenesis
was markedly reduced after prolonged fasting. Consistent with our
recent observations, these results indicated that a systemic change
in metabolism was likely caused by a reduction in the FA uptake in
the heart and skeletal muscle as well as compensatory glucose
consumption in these tissues, thus linking endothelial FABP4/5 to
the regulation of systemic energy homeostasis during the fasting
condition (figure 9).
Distinct Mechanisms of Hepatic Fat Accumulation in DKO
Mice
The potential mechanisms contributing to the excessive
accumulation of fat in the liver include increased fat delivery,
increased fat synthesis, reduced fat oxidation, and/or reduced fat
export in the form of VLDL. Among these mechanisms, hepatic
steatosis in DKO mice is likely to be largely attributed to increased
fat delivery into the liver. Hepatocytes can take up to 30% of
circulating NEFA, which may exceed its capacity for FA [19].
Thus, increased levels of circulating NEFA, as observed in DKO
mice during fasting, may be one of the major causes of prominent
fatty liver. In addition, the uptake of
125I-BMIPP by the liver was
increased in DKO mice during fasting, which further supports this
Figure 5. Rate of FA oxidation is enhanced in DKO mice. (A and B) Livers were isolated before (0 hour) and after fasting (24- and 48-hr). (A) The
expression of genes involved in FA metabolism was determined using quantitative real-time PCR. (B) The indicated metabolites from the livers of WT
and DKO mice after 48 hr fast were measured using metabolom ea n a l y s i s .n = 7 / g r o u p .N o t et h a te n e r g yc h a r g e( ( A T P +1/2ADP)/
(ATP+ADP+AMP)=0.51, more than 0.5 guarantees sampling quality) served as a quality control of material handlings [32,33]. The lactate/pyruvate
ratio was higher compared to previous reports [34], which might be due to technological differences between the enzymatic/chemical approach
used in previous studies and the CE-MS approach used in this study. (C) Estimation of FAO using primary cultures of hepatocytes. n=10/group. (D)
Estimation of FAO using liver homogenates before (0-hr) and after fasting (24- and 48-hr). n=6/group. Data are shown as the mean 6 SE. WT vs. DKO.
!p,0.05, !!p,0.01, !!!p,0.001.
doi:10.1371/journal.pone.0079386.g005
FABP4/5-Null Mice with Defective Peripheral FA Use
PLOS ONE | www.plosone.org 6 November 2013 | Volume 8 | Issue 11 | e79386hypothesis. Our study using tyloxapol, a LPL inhibitor, showed
that VLDL secretion in the liver was diminished in DKO livers
after 24-hr fast, which was consistent with the reduced expression
of genes associated with VLDL formation, such as Apo-B100. In
addition, we showed an increased level of serum glucagon, which
may further facilitate steatosis due to glucagon suppression of
VLDL secretion [17]. Our data excluded the possible contribution
of reduced FAO because the FAO rate by liver extracts was
significantly increased in DKO mice compared to WT mice.
Taken together, these data indicate that an increase in circulating
NEFA and a reduced fat export in the form of VLDL contribute to
hepatic steatosis in DKO mice during prolonged fasting.
Mechanisms Underlying Pronounced Hypoglycemia
during Fasting in DKO Mice
One of the salient features of the metabolism in DKO
mice was pronounced hypoglycemia compared to WT mice
during prolonged fasting. Extreme hypoglycemia maybe attrib-
uted to two major causes; remarkable glucose consumption by
Table 1. Metabolome analyses of DKO livers.
Amino Acid WT FABP4/5 DKO
Glucogenic Non
essential
Alanine 524.16296.2 185.3645.6*
Arginine 3.760.6 2.160.5***
Asparagine 80.6619.1 28.965.8***
Aspartate 305.0644.3 247.9665.2
Cysteine 5.863.8 1.962.1*
Glutamate 1130.96231.8 1842.16308.7***
Glutamine 1455.16410.0 1963.46715.4
Glycine 784.36249.3 887.96264.6
Proline 84.7616.7 60.2611.9**
Serine 344.26136.3 189.4662.8*
Glucogenic and
Ketogenic
Tyrosine 43.969.7 30.4610.2*
Glucogenic Essential
Histidine 230.8637.6 288.5668.3
Methionine 14.065.9 6.760.5*
Threonine 102.1637.3 61.3618.4*
Valine 330.5691.9 196.4665.6**
Glucogenic and
Ketogenic
Isoleucine 111.6632.0 70.5627.0*
Phenylalanine 60.6614.4 46.3610.1
Tryptophan 13.962.9 10.263.0*
Ketogenic
Leucine 246.4673.0 196.8670.3
Lysine 254.8681.3 135.5635.3**
(nmol/g weight).
Indicated metabolites from the livers of WT and DKO mice after 48-hour of
fasting were measured using capillary electrophoresis-mass spectrometry
(n=7).
Data are shown as the mean 6 SE. WT vs. DKO.
*p,0.05, **p,0.01, ***p,0.001.
doi:10.1371/journal.pone.0079386.t001
Figure 6. Fasting-induced hepatic steatosis is reversible. (A)
DKO mice fasted for 48 hours. After resuming food intake, blood and
liver samples were collected at the indicated time points (24-, 48- or 72-
hr after refeeding). Mice that did not undergo fasting (0-hr) or
experienced 48 hours of fasting were used as controls. The TG content
in the liver and the serum levels of biochemical parameters (NEFA,
ketone bodies, TG and glucose) were measured as previously described
in the Materials and Methods section. n=5211/group. Data are shown
as the mean 6 SE. Control vs. no fasting/refeeding !!p,0.01,
!!!p,0.001.
doi:10.1371/journal.pone.0079386.g006
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is accelerated in FA-burning tissues, such as the heart and red
skeletal muscle, to compensate for restricted FA utilization due
to impaired FA uptake via capillary endothelial cells [14]. The
dramatic increase in glucose utilization during fasting was
insulin-independent and was at least partially attributed to the
post-transcriptional and allosteric regulation of key proteins that
regulate glucose uptake and glycolysis [14]. Although gluconeo-
genesis was conserved at a 3-hr fast, it was significantly reduced
at a 24-hr fast. Metabolome analysis revealed that gluconeo-
genic materials such as lactate, most amino acids and co-factors
(NAD, NADH and GTP) were markedly reduced in DKO
Figure 7. Impaired glucose homeostasis in DKO mice during prolonged fasting. (A to E) Livers were isolated before (0-hr) and after fasting
(24- and 48-hr). (A) Glycogen storage in the liver of WT and DKO. n=8/group (B) Representative PAS staining of the liver of the WT and DKO mice.
Scale bar=100 mm. (C and D) The indicated metabolites from the livers of WT and DKO mice after 48-hr fast were measured using metabolome
analysis. n=7/group. (E) The expression of genes involved in gluconeogenesis was determined using quantitative real-time PCR. (F) Estimated
gluconeogenesis using the pyruvate challenge test. After 24 hour of fasting, pyruvate (2 gram/kg) was intraperitoneally injected. Blood was taken
from the tail vein to measure the blood glucose levels at the indicated time points. n=6/group. Data are shown as the mean 6 SE. WT vs. DKO.
!p,0.05, !!p,0.01, !!!p,0.001.
doi:10.1371/journal.pone.0079386.g007
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concentration and an increase in the glucagon/insulin ratio in
DKO mice during fasting suggested that gluconeogenesis was
accelerated at least transiently. Taken together, gluconeogenesis
was most likely accelerated to maintain the glucose levels shortly
after fasting, which resulted in lower levels of gluconeogenic
substrates during prolonged fasting, thereby leading to a
reduced ability of subsequent gluconeogenesis at later time
periods. However, it is still uncertain whether the acceleration
of gluconeogenesis and/or other mechanisms was directly
related to a decrease in gluconeogenic substrates. Our data
suggested that elevated glucose consumption by peripheral
tissues as well as the subsequent reduction of gluconeogenesis
caused marked hypoglycemia during fasting.
Hyperketonemia is a Unique Feature in DKO Mice
The mechanisms of increased levels of circulating ketone
bodies in DKO mice deserve further discussion. Since FAO is
elevated in the liver of DKO mice independent of fasting
(figure 5D), an abundant supply of NEFA into hepatocytes
(figure 1 and 2E) and a lower level of blood glucose during
fasting (figure 1) likely promoted ketogenesis (figure 8) in
combination with an enhanced expression of genes involved in
ketogenesis (figure 7B). Hyperketonemia is a unique feature in
DKO mice with defective peripheral FA utilization when
compared with other mice lacking FA utilization. Mice deficient
for FAO-associated genes, such as MCAD, LCAD and PPARa,
showed metabolic changes that were very similar to DKO mice
in response to fasting, such as marked steatosis, hypoglycemia
and an elevated level of serum NEFA[1–4]. However, they did
not have hyperketonemia, but did exhibit hypoketonemia or
normoketonemia. Although FA utilization was disrupted in the
heart and red skeletal muscle at the capillary level in DKO
mice, FAO was conserved or even increased in the liver.
However, in mice lacking FAO-associated genes, FAO was
disrupted at different steps of the pathway and to varying
degrees in most tissues, including the liver. Moreover, NEFA
was efficiently converted into ketone bodies without functional
disturbance of FAO in DKO livers, whereas most of the NEFA
accumulated as TG without efficient oxidation in the liver in
mice deficient for FAO-associated genes. Thus, our data
demonstrated that DKO mice exhibited distinct features of
ketone body metabolism and hyperketonemia, which was in
sharp contrast to the hypoketonemia/normoketonemia reported
in mice lacking FAO-associated genes, where common charac-
teristics such as marked steatosis, hypoglycemia and an elevated
level of serum NEFA were observed.
In summary, we showed that a loss of FABP4/5 resulted in
hyperketotic hypoglycemia and marked hepatic steatosis during
prolonged fasting. Together with our previous study demonstrat-
ing that DKO mice exhibit defective FA uptake in the heart and
red skeletal muscle across capillary endothelial cells and a
compensatory increase in glucose uptake in these tissues, the
results in the present study established FABP4/5 as important
components of the systemic adaptive response to fasting, and may
have important implications for understanding the metabolic
consequences of defective peripheral FA uptake, as well as for
developing a novel strategy to control energy homeostasis via the
selective modulation of FA uptake.
Materials and Methods
Mice and Sample Collection
Mice with a homozygous null mutation in Fabp4 (Fabp42/2)
or Fabp5 (Fabp52/2) were generated as previously described
[6,7]. Mice deficient for both Fabp4 and Fabp5 (DKO mice)
were generated from an intercross between Fabp4(2/2) and
Fabp5(2/2) mice as previously described [9]. The background
strain of the wild-type and knockout mice was C57BL6J. The
Institutional Animal Care and Use Committee (Gunma
University Graduate School of Medicine) approved all study
protocols. The mice were housed in a temperature-controlled
room in a 12-hour light/12-hour dark cycle and had
unrestricted access to water and standard chow (CE-2, Clea
Japan, Inc.). Twelve to eighteen week-old mice from both
genotypes were used. For the fasting experiments, the mice were
individually housed and food was withdrawn for 24 or 48 hr;
water was provided ad libitum. A portion of the liver was
snapped frozen in liquid nitrogen and kept at 280uC until
further use. The rest of the liver was processed for histological
Figure 8. Ketogenesis is enhanced in DKO mice. (A) The indicated metabolites from the livers of WT and DKO mice after 48 hours of fasting
were measured using metabolome analysis. n=7/group. (B) The expression of genes involved in ketogenesis was determined using quantitative real-
time PCR. n=4/group. WT vs.DKO. !p,0.05, !!p,0.01.
doi:10.1371/journal.pone.0079386.g008
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ACTIMO-100 (SHINFACTORY, Fukuoka, Japan).
Measurement of Blood Parameters
Blood was collected from the vena cava inferior and centrifuged
at 1,5006g for 15 minutes at 4uC to separate the serum. Blood
glucose was measured using the glutest sensor (Sanwa Kagaku,
Aichi, Japan). Serum levels of insulin (Ultrasensitive Mouse Insulin
ELISA, Mercodia, Uppsala, Sweden), ketone bodies (EnzyChrom
Ketone Body Assay Kit, BioAssaySystems, California), triglycer-
ides (Triglyceride E-test, Wako Chemical, Osaka), non-esterified
fatty acids (NEFA C-test, Wako Chemical, Osaka) and total
cholesterol (Cholesterol E-test, Wako Chemical, Osaka) were
measured according to the manufacturer’s protocols. Blood for
glucagon measurement was separately collected from the retro-
orbital plexus and transferred into a tube containing aprotinin
(500 KIU/ml). Glucagon was measured according to the manu-
facturer’s protocol (Glucagon RIA kit, Millipore, USA).
Triglyceride Measurements in the Liver
Livers were homogenized in RIPA buffer (50 mM Tris-HCl,
pH 7.4, 1% NP40, 0.25% Na-deoxycholate, 150 mM NaCl and
1mM EDTA) and centrifuged at 18,0006g for 10 minutes at 4uC.
Lipids in the supernatant were extracted with methanol/chloro-
form (1:2), evaporated with NO2 and dissolved in isopropanol.
Triglyceride contents were determined using the Triglyceride E-
test Wako (Wako Chemical, Osaka) and were expressed as
milligrams of lipid per gram of protein.
Glycogen Measurements in the Liver
Liver samples were immediately snap-frozen in liquid nitrogen
and pulverized using a mortar and pestle in liquid nitrogen. Ten
milligrams of liver powder was resuspended in distilled water and
then boiled for 5 minutes. After centrifugation, the supernatants
were collected to measure the glycogen concentration (BioVision).
Histological Analysis
For oil red O stain, the liver was fixed with 4% paraformal-
dehyde, embedded in OCT compound (Tissue-Tek, Netherlands)
and frozen in liquid nitrogen. Cryosections (10 mm) were
immersed for 10 minutes in 0.3% oil red O in isopropanol. For
PAS staining, the liver was fixed with 4% paraformaldehyde and
embedded in paraffin.
RNA Isolation and Reverse Transcription (RT)–PCR
Total RNA was isolated from various organs using TRIzol
reagent (Invitrogen). Semi-quantitative RT-PCR was performed
using the RT-PCR kit (TAKARA, Japan) according to the
manufacturer’s protocol. Quantitative real time-PCR was per-
formed with the SYBR Green PCR Master Mix (Applied
Biosystems) according to the manufacturer’s instructions. The
expression level of the target gene was normalized against
GAPDH mRNA levels. The gene-specific primers for cDNA used
in this study are listed in table 2.
Isolation of Hepatocytes from Mice
Primary cultures of hepatocytes from adult mice were prepared
as previously described by Li et al. with slight modifications [24].
Under anesthetized conditions, the liver was perfused with
perfusion medium I (10 mM HEPES, 0.05% KCl, 5 mM glucose
and 0.2 mM EDTA, in phosphate-buffered saline [PBS] at
pH 7.4) from the vena cava using a peristaltic pump (5 ml/min)
for 8 minutes to the portal vein, which was cut after needle
insertion. Next, perfusion medium II (30 mM HEPES, 0.05%
KCl, 5 mM glucose and 1 mM CaCl2 in PBS at pH 7.4)
containing 0.8 mg/ml of collagenase L (Nitta Gelatin) was used
to digest the tissue for 8 minutes. After digestion and removal of
the gall bladder and unrelated tissues, the liver was minced into
small pieces and filtered into a new tube via a gauze mesh filter.
Hepatocytes were centrifuged at 506g for 2 minutes and washed
with perfusion medium II three times, and then re-suspended with
hepatocyte medium (DMEM high glucose containing 2 mM
glutamine, 1% non-essential amino acids, 10% fetal bovine serum,
1% penicillin/streptomycin, 50 mg/ml of gentamycin. After an
overnight incubation, the
14C-Palmitic acid uptake assay or b-
oxidation assay was performed as described below.
Figure 9. Working model of metabolic changes in DKO mice
during fasting. (A) In WT mice, TG in adipose tissue is hydrolyzed
during prolonged fasting, which releases NEFA into circulation. NEFA is
taken up by various organs, including the heart, skeletal muscle and the
liver as central energy substrates, which spares glucose consumption
for glucose-dependent tissues, such as the brain and red blood cells. (B)
However, in DKO mice, circulating NEFA cannot be efficiently taken up
by the heart and skeletal muscle due to impaired FA transport via
capillary ECs, which results in an increase in NEFA influx into the liver
and FA accumulation in the liver. To compensate for the reduced
uptake of NEFA, glucose uptake by the heart and red skeletal muscle is
markedly enhanced independently of insulin even during fasting [14],
which causes hypoglycemia. Although gluconeogenesis is conserved to
supply glucose to peripheral tissues shortly after fasting, substrates for
gluconeogenesis are reduced, resulting in insufficient gluconeogenesis
during prolonged fasting, which further enhances hypoglycemia. FAO
was enhanced during the fed state and a higher level of FAO was
maintained even after prolonged fasting. Combined metabolic changes,
including increased NEFA influx into the liver, enhanced FAO and lower
blood glucose, accelerate ketogenesis. Please refer to the text and
discussion for further details. Thick arrows indicate more flow; thin
arrows indicate less flow; dotted arrow indicates impaired flow.
doi:10.1371/journal.pone.0079386.g009
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Hepatocytes were plated in 6-well plates at density of 1 610
5
cells and pre-incubated in serum-free DMEM (Invitrogen) for
thirty minutes. To determine the dose-related uptake, hepatocytes
were incubated with 0.18 kBq (low dose) and 3 kBq
14C-palmitic
acid (high dose) with FA-free bovine serum albumin (BSA) as a
carrier. After 10 minutes, the cells were washed with ice-cold stop
buffer (0.1% BSA and 0.2 mM phloretin in PBS) three times and
lysed in lysis buffer (0.1 N NaOH, 0.2% SDS). Supernatants were
collected into tubes containing 4 ml of scintillation cocktail
(Aquasol2; Perkin Elmer). The radioactivity of the cell lysate was
determined using the liquid scintillation counter (LCS-3000;
Aloka). The experiments were performed independently three
times.
Palmitic Acid Oxidation Studies in Cultured Hepatocytes
Fatty acid oxidation in primary culture of hepatocytes was
assessed by measuring the production of
14CO2as previously
described [25]. Briefly, isolated hepatocytes were plated in a T25
flask at a density of 1 610
6 cells and pre-incubated in glucose-free
DMEM (Invitrogen) for thirty minutes. The cells were treated with
14C-palmitic acid (Perkin Elmer, CT, USA) with FA-free BSA as a
carrier and a piece of wet Whatman filter paper with 2N sodium
hydroxide was suspended within each flask. The flasks were sealed,
and 7 hours later, the cells were lysed in 6N hydrochloric acid and
then further incubated overnight. The
14CO2 produced was
trapped on the Whatman paper and was quantified using
scintillation counting.
NEFA b Oxidation in Liver Homogenates
The beta oxidation ability of liver homogenates was examined
as previously described [17]. One hundred milligrams of liver was
manually homogenized using a Potter-Elvejhem homogenizer in
2 ml of ice-cold isolation buffer (220 mM mannitol, 70 mM
sucrose, 2 mM HEPES, and 0.1 mM EDTA at pH 7.4). Aliquots
of the homogenate (300 ml) were added to 1.7 ml of reaction
medium (50 mM sucrose, 150 mM Tris-HCl, 20 mM KH2PO4,
10 mM MgCl2, 2 mM EDTA, 1 mM L-carnitine, 0.2 mM CoA,
2 mM NAD, 0.1 mM malate, 10 mM ATP, 1 mM palmitate
complexed to fatty acid-free albumin at a 5:1 molar ratio in
Williams E medium, 12 kBq of
14C-palmitic acid [Perkin Elmer,
CT, USA], pH 7.4). The reactions were performed in a sealed
flask and were placed in a 37uC incubator for 30 minutes. The
incubations were terminated by the addition of 1 ml of 6N
hydrochloric acid to the reaction medium to precipitate proteins
and non-metabolized palmitate. The sample was further incubated
at room temperature for 2 hours to collect
14CO2 into a suspended
well containing 250 ml of ethanolamine. Blanks were prepared by
acidification of the reaction medium immediately after the
addition of the homogenate. Radioactivity in
14CO2 was
quantified using liquid scintillation counting.
Biodistribution of
125I-BMIPP (15-(p-iodophenyl)-3-(R,S)-
methyl Pentadecanoic Acid) and
18F-FDG (2-
fluorodeoxyglucose)
The biodistribution of
125I-BMIPP and
18F-FDG was deter-
mined as previously described[26–28]. Mice received intravenous
injections of
125I-BMIPP (5 kBq) and
18F-FDG (100 kBq) via the
lateral tail vein in a volume of 100 ml.
125I-BMIPP was a gift from
Table 2. Primer for RT-PCR.
Forward Reverse
mACC GAATCCTCATTGGCTTACGATGAG AATGGCCCGGCATGT
mACSL1 GAACAGAGTGAAGCCCAAGC CAGGCTGTTTCTGACGA
mApoB100 CGTGCAAGAACTGGCTGATA CAGCGCTCCAAGTGACATTA
mCPT1a CCATGAAGCCCTCAAACAGATC ATCACACCCACCACCACGATA
mCPT2 TCCTCGATCAAGATGGGAAC GATCCTTCATCGGGAAGTCA
mELOVL6 CCCGAACTAGGTGACACGAT TACTCAGCCTTCGTGGCTTT
mFABP1 CATCCAGAAAGGGAAGGACA TTTTCCCCAGTCATGGTCTC
mFAS GCTGCGGAAACTTCAGGAAAT AGAGACGTGTCACTCCTGGACTT
mFAT/
CD36
GAGCAACTGGTGGATGGTTT TGGGTTTTGCACATCAAAGA
mFATP2 GGTATGGGACAGGCCTTGCT GGGCATTGTGGTATAGATGACATC
mFGF21 CTGGGGGTCTACCAAGCATA GTCCTCCAGCAGCAGTTCTC
mG6Pase CCAGTCGACTCGCTATCTCC CAAGGTAGATCCGGGACAGA
mGAPDH AGCCCCCAGTCTGTATCCTT TCCACCACCCTGTTGCTGTA
mHMGCL ACTACCCAGTCCTGACTCCAA TAGAGCAGTTCGCGTTCTTCC
mHMGCS2 ATACCACCAACGCCTGTTATGG CAATGTCACCACAGACCACCAG
mPEPCK1 CGATGACATCGCCTGGATGA TCTTGCCCTTGTGTTCTGCA
mPPARa AGAGCCCCATCTGTCCTCTC ACTGGTAGTCTGCAAAACCAAA
mSCD1 GCTGGGCAGGAACTAGTGAG GGTAGGGAGGATCTGGAAGC
RT PCR indicates Real Time Polymerase Chain Reaction; ACC, acetyl CoA aarboxylase; ACSL1, acyl-CoA synthetase long-chain family member 1; ApoB100, apolipoprotein
B100; CPT, carnitinepalmitoyltransferase; FABP1, fatty acid binding protein 1; FAS, fatty acid synthase; FAT, fatty acid translocase; FATP2, fatty acid transport protein 2;
FGF21, fibroblast growth factor 21; G6Pase, glucose-6-phosphatase; GAPDH, glyceraldehyde-3-phosphate dehydrogenase, HMGCL, 3-hydroxymethyl-3-methylglutaryl-
CoA lyase; HMGCS2, 3-hydroxy-3-methylglutaryl-CoA synthase 2; PEPCK1, phosphoenolpyruvatecarboxykinase 1, PPARa, peroxisome proliferator-activated receptor a,
SCD1, stearoyl-coA desaturase 1.
doi:10.1371/journal.pone.0079386.t002
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18F-FDG was obtained from
batches prepared for clinical PET imaging at Gunma University.
The animals were sacrificed 2 hours after the injection. The
isolated tissues were weighed and quantified using a well-type
gamma counter (ARC-7001, ALOKA). Each experiment was
performed at least twice.
Pyruvate Challenge Test
After 3- or 24-hr fast, pyruvate (2 gram/kg body weight, Sigma)
was injected intraperitoneally. Blood was taken from the tail vein
to measure the level of glucose using the glutest sensor (Sanwa
Kagaku, Aichi, Japan) at the indicated time points [29].
Hepatic TG-VLDL Production
After 24 hours of fasting, the mice were intravenously injected in
the tail vein with Triton WR 1339 (500 mg/kg body weight in
0.9% NaCl), which inhibits the enzymatic activity of lipoprotein
lipase [30]. Blood was sampled before (0 hour) and after (1, 2 and
6 hours) the injection. TG was measured enzymatically as
previously described. The TG-VLDL production rate was
calculated from the difference in plasma TG levels over a given
interval following detergent injection and was expressed as mmol/
kg/h as previously reported [30].
Metabolome Analysis Using CE-MS
Metabolome analyses were performed as described elsewhere
[31]. The abdomen of the mouse was opened by a midline incision
under isoflurane anesthesia, which did not stop breathing and the
heart beat. A portion of the liver was rapidly removed from the
mice at 3 months of age after a 48-hr fast. The time between
isolating the liver and snap-freezing it in liquid nitrogen was within
several seconds and the tissue was stored at 280uC.
Metabolite extraction. Frozen liver tissue was immediately
immersed into methanol (1 ml) containing internal standards
(300 mM each of methionine sulfone for cations and MES for
anions) and homogenized for 1 minute to inactivate enzymes.
Next, deionized water (500 ml) was added, and 300 ml of the
solution was transferred into another tube. Subsequently, 200 mlo f
chloroform was added, and the mixture was thoroughly mixed.
The solution was then centrifuged at 12,0006g for 15 minutes at
4uC, and 300 ml of the upper aqueous layer was centrifugally
filtered through a Millipore 5-kDa cutoff filter to remove proteins.
The filtrate was lyophilized and dissolved in 50 ml of Milli-Q water
containing the reference compounds (200 mM each of 3-
aminopyrrolidine and trimesate) prior to CE-MS analysis.
Metabolic standards. All of the chemical standards were
obtained from common commercial sources and dissolved in Milli-
Q (Millipore) water, 0.1 N HCl or 0.1 N NaOH to obtain 10 mM
or 100 mM stock solutions. Working standard mixtures were
prepared by diluting the stock solutions with Milli-Q water just
prior to the injection into the CE-MS. The chemicals used were of
analytical or reagent grade.
Instrument. All CE-MS experiments were performed using
the Agilent CE Capillary Electrophoresis System equipped with an
air pressure pump, the Agilent 1100 series MSD mass spectrom-
eter, and the Agilent 1100 series isocratic high performance liquid
chromatography pump, a G1603A Agilent CE-MS adapter kit,
and a G1607A Agilent CE-MS sprayer kit (Agilent Technologies).
System control, data acquisition, and MSD data evaluation were
performed using the G2201AA Agilent Chem Station software for
CE-MSD.
CE-MS conditions for cationic metabolites. Separations
were performed in a fused silica capillary (50 mm inner diameter x
100 cm total length) filled with 1 M formic acid as the electrolyte.
Approximately 3 nl of the sample solution was injected at 50 mbar
for 3 seconds, and the voltage was applied at 30 kV. The ESI-MS
was performed in the positive ion mode, and the capillary voltage
was set at 4000 V. For MS, using the selective ion monitoring
mode, deprotonated [M+H]
+ ions were monitored for cationic
metabolites of interest.
CE-MS conditions for anionic metabolites. A cationic
polymer-coated SMILE (+) capillary was obtained from Nacalai
Tesque (Kyoto, Japan) and used as the separation capillary (50 mm
inner diameter6100 cm total length). The electrolyte for the CE
separation was 50 mM ammonium acetate solution (pH 8.5). The
samples were injected with a pressure injection of 50 mbar for 30
seconds (30 nl). The applied voltage was set at -30 kV. ESI-MS
was performed in the negative ion mode, and the capillary voltage
was set at 3500 V. For MS, using the selective ion monitoring
mode, deprotonated [M–H]
2 ions were monitored for anionic
metabolites of interest.
Statistical Analysis
Statistical analysis was performed using unpaired Student’s t-test
for 2 samples. One way ANOVA was performed for 3 samples and
Bonferroni’s post hoc multiple comparison tests were performed to
evaluate differences between the control and experimental groups.
A p-value of ,0.05 was considered statistically significant.
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